Active Filter(s):
Details:
The financing will support further clinical trials of its lead product, FibroFix™, at Southmead Hospital Bristol, UK and in Budapest, Hungary. FibroFix is unique in emulating the functional properties of cartilage while also facilitating rapid tissue regeneration.
Lead Product(s): Fibroin
Therapeutic Area: Orthopedics/Orthopedic Surgery Product Name: FibroFix
Highest Development Status: Undisclosed Product Type: Large molecule
Partner/Sponsor/Collaborator: Parkwalk
Deal Size: $12.5 million Upfront Cash: Undisclosed
Deal Type: Series A Financing February 09, 2022